Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 13;16(6):254-261.
doi: 10.1002/cld.978. eCollection 2020 Dec.

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable

Radha K Dhiman  1   2   3   4 , Madhumita Premkumar  1
Affiliations
Review

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable

Radha K Dhiman et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

FIG 1
FIG 1
Global programs for HCV elimination. Reproduced with permission from Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY‐NC‐SA 3.0 IGO.
FIG 2
FIG 2
(A) Global prevalence estimates of HCV as per WHO data (2015). (B) Global incidence estimates of HCV as per WHO data (2015). Reprinted with permission from World Health Organization (WHO), work conducted by the Centre for Disease Analysis, Global Hepatitis Report 2017.
FIG 3
FIG 3
HCV cascade of care. Of the 3.5 million estimated PLHCVs in the United States, only 20% have been screened by serological tests and then only 27% have NATs for confirmation; still fewer with disease staging, treatment initiation, and adherence; and finally, only 9% of the total pool achieves cure.
See this image and copyright information in PMC

References

    1. World Health Organization . Global Health Sector Strategy on Viral Hepatitis 2016‐2021: towards ending viral hepatitis. WHO/HIV/2016.06. Available at: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Accessed June 15, 2019.
    1. World Health Organization . Global Hepatitis Report. Geneva: World Health Organization; 2017.
    1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;388:1081‐1088. - PMC - PubMed
    1. World Health Organization . Progress report on access to hepatitis C treatment. Focus on overcoming barriers in low‐ and middle‐income countries. WHO/CDS/HIV/18.4. Available at: http://apps.who.int/iris/bitstream/10665/260445/1/WHO-CDS-HIV-18.4-eng.p.... Published March 2018. Accessed June 21, 2019.
    1. Chugh Y, Dhiman RK, Premkumar M, et al. Real‐world cost‐effectiveness of pan‐genotypic Sofosbuvir‐Velpatasvir combination versus genotype dependent directly acting anti‐viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India. PLoS One 2019;14:e0221769. - PMC - PubMed